Health in the Americas 2022



The Health in the Americas+ country profiles are based on the interagency indicators available as of the dates referenced. The sources are referenced in this table. In some cases, the values of the indicators may differ from the most recent data available in the country.

Environmental and social determinants of health

In 2000, the total population of Guadeloupe was 424,067, and by 2020 it had decreased to 395,642, representing a decrease of 7% over the period. In terms of the country's demographic profile, the population aged 65 and over-represented 19.2% of the total in 2020, an increase of 9.4 percentage points over 2000. Likewise, a ratio of 120.8 women for every 100 men and 102.6 older adults (aged 65 and over) for every 100 children under 15 years of age was reached in 2020. If the population aged 15 to 64 years is considered potentially active, i.e., susceptible to participate in labor activities, it represented 62.2% of the total population of Guadeloupe in 2020, which is equivalent to 243.735 people. Thus, considering the potentially passive population (73,993 children under 15 years of age and 75,915 people aged 65 and over), the potential dependency ratio was 61 potentially passive inhabitants for every 100 potentially active inhabitants. This dependency ratio was 54.2 in 2000.

Life expectancy at birth in 2021 was 82.74 years - higher than the average for the Region of the Americas - representing an increase of 7 years over the 2000 figure.

Figure 1. Population pyramids of Guadeloupe, years 2000 and 2021


The unemployment rate in 2019 was 28.7% of the total population. In addition, 34.5% of the population was below the national poverty line in 2017. The literacy rate in Guadeloupe was 96% in 2014. Among men, this indicator rose to 95.5%, while among women, it was 96.4%.

Health situation

Maternal and child health

Between the years 2010 and 2021, infant mortality decreased from 7 to 5.8 per 1 000 live births. This represents an increase of 17%.

In the specific case of adolescent fertility, there has been a 34.7% reduction, from 21.6 live births per 1,000 women aged 15 to 19 years in 2000 to 14.1 in 2021. also recorded a percentage coverage of births attended by trained personnel of 100% by 2016.

In relation to fertility, it is estimated that in 2020 women had an average of 2.33 children throughout their reproductive lives.

Communicable diseases

In turn, the rate of new HIV diagnoses per 100 000 population was estimated at 18.5 for 2017.

Noncommunicable diseases and risk factors

In Guadeloupe, the prevalence of tobacco use among people aged 15 and older was 16,5% in 2014. The prevalence of diabetes mellitus was 8.1 in 2013.


The crude mortality rate was 8.9 per 1000 population in 2019, an increase of 25% compared to 2009 (7.1 deaths per 1000 population).

Status of the COVID-19 pandemic

In 2020, a total of 8 620 cases of COVID-19 were identified in Guadeloupe, representing 21 543.2 per million inhabitants. In 2021, 47,175 cases were identified, equivalent to 117,933.7 per million inhabitants in the country. In terms of deaths directly caused by COVID-19, in 2020, 155 deaths of persons diagnosed with COVID-19 were recorded in Guadeloupe, or 387.4 per million inhabitants, while in 2021, the country recorded 676 deaths due to COVID-19, representing 1 689.9 deaths per million inhabitants. In the Region of the Americas, Guadeloupe ranked 27th in the number of deaths from COVID-19 in 2020 and 27th in 2021.

By December 31, 2021, 37% of the country's population had at least one dose of the COVID-19 vaccine. By April 20, 2022 (the latest available data), 35% of the population was fully vaccinated. The vaccination campaign started on January 20, 2021, and 6 types of COVID-19 vaccines have been used so far in the country.

Figure 7. Cumulative COVID-19 deaths in the Region of the Americas, to 31 December 2022

The sources of the interagency indicators used in this profile can be found in this table.

For the latest data on health indicators for the Region of the Americas, be sure to visit the PAHO Core Indicators portal.